Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5677953 | 0.94 | PSMB5 (0.40) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL5682158 | 0.94 | PSMB5 (0.40) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL5682124 | 0.84 | POLB (0.45) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL5682035 | 0.82 | POLB (0.44) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL7465906 | 0.82 | POLB (0.44) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL7980355 | 0.81 | POLB (0.43) | POLBSYKCTSKMAPTGAA | |
| SCHEMBL7980357 | 0.81 | POLB (0.43) | POLBSYKCTSKMAPTGAA | |
| SCHEMBL9327711 | 0.80 | CTSK (0.48) | POLBSYKCTSKMAPTGAA | |
| SCHEMBL7043663 | 0.80 | PSMB5 (0.42) | POLBPSMB5SYKCTSKMAPT | |
| SCHEMBL7043661 | 0.80 | PSMB5 (0.42) | POLBPSMB5SYKCTSKMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |
| EP-1089964-A1 | HYDRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000000465-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-06 | — | — | WO | disclosed |